首页> 中文期刊> 《中国药理学与毒理学杂志》 >MicroRNA-10a promotes granulosa cells tumor development

MicroRNA-10a promotes granulosa cells tumor development

         

摘要

OBJECTIVE To investigate the effect of microRNA-10a on the development of granulosa cells tumor (GCT). METHODS FISH was used to detect the miR-10a expression in tissues from GCT patients. Several functional assays were performed to investigate the effect of miR-10a on proliferation,migration, invasion, spheroid formation and repressed anticancer drug-induced apoptosis of GCT in vitro.CRISPR- Cas9 system mediated miR- 10a knockout in cancer GC and two mice GCT models wereconstructed to show the knockdown effect of miR-10a on cancer GC both in vitro and in vivo. RNA-seq,Western blot, luciferase reporter assay and FISH were used to identify potential direct functional targets and related pathways of miR-10a in cancer GC. RESULTS Strong miR-10a signal was detected in tissues from malignant GCT patients. And amplification of miR- 10a negatively correlated with overall survival rate of ovarian cancer patients. In addition, ectopic expression of miR- 10a significantly promoted cell proliferation, migration, invasion, spheroid formation and repressed anticancer drug-induced apoptosis in vitro. CRISPR-Cas9 system mediated miR-10a knockout in cancer GC showed opposite phenotype compared to miR-10a overexpressed cancer GC. By using xenograft and orthotropic models, the onco?genic role of miR-10a was further confirmed in vivo. RNA-seq, Western blot, luciferase reporter assay and FISH were used to identified PTEN/TET2 as direct functional targets of miR-10a in cancer GC; Akt and Wnt were found as two associated signaling pathways of miR- 10a in cancer GC. CONCLUSION Taken together, our results demonstrate that the miR-10a is positively involved in development of GCT.

著录项

  • 来源
    《中国药理学与毒理学杂志》 |2017年第10期|973|共1页
  • 作者

    Jia-jie TU; Wei WEI;

  • 作者单位

    Institute of Clinical Pharmacology;

    Anhui Medical University;

    Key Laboratory of Anti-inflammatory and Immune Medicine;

    Ministry of Education;

    Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine;

    Hefei 230032;

    China;

    Institute of Clinical Pharmacology;

    Anhui Medical University;

    Key Laboratory of Anti-inflammatory and Immune Medicine;

    Ministry of Education;

    Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine;

    Hefei 230032;

    China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号